Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial.
Seth A, Onuma Y, Costa R, Chandra P, Bahl VK, Manjunath CN, Mahajan AU, Kumar V, Goel PK, Wander GS, Kalarickal MS, Kaul U, Kumar VKA, Rath PC, Trehan V, Sengottuvelu G, Mishra S, Abizaid A, Serruys PW. Seth A, et al. EuroIntervention. 2017 Jul 20;13(4):415-423. doi: 10.4244/EIJ-D-17-00306. EuroIntervention. 2017. PMID: 28504218 Free article. Clinical Trial.
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study.
Onuma Y, Tanimoto S, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Dorange C, Miquel-Hebert K, Veldhof S, Serruys PW. Onuma Y, et al. Among authors: seth a. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):634-42. doi: 10.1002/ccd.22541. Catheter Cardiovasc Interv. 2010. PMID: 20690152 Clinical Trial.
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Worthley S; e-SELECT Investigators. Urban P, et al. J Am Coll Cardiol. 2011 Mar 29;57(13):1445-54. doi: 10.1016/j.jacc.2010.11.028. J Am Coll Cardiol. 2011. PMID: 21435513 Free article.
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S, Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators. Abizaid A, et al. JACC Cardiovasc Interv. 2012 Jan;5(1):64-71. doi: 10.1016/j.jcin.2011.09.016. JACC Cardiovasc Interv. 2012. PMID: 22230152 Free article.
The Cardiological Society of India.
Kalarickal MS, Seth A. Kalarickal MS, et al. Among authors: seth a. Circ J. 2012;76(7):1540-1. doi: 10.1253/circj.cj-66-0032. Epub 2012 Jun 2. Circ J. 2012. PMID: 22664725 Free article. No abstract available.
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
Muramatsu T, Onuma Y, van Geuns RJ, Chevalier B, Patel TM, Seth A, Diletti R, García-García HM, Dorange CC, Veldhof S, Cheong WF, Ozaki Y, Whitbourn R, Bartorelli A, Stone GW, Abizaid A, Serruys PW; ABSORB Cohort B Investigators; ABSORB EXTEND Investigators; SPIRIT FIRST Investigators; SPIRIT II Investigators; SPIRIT III Investigators; SPIRIT IV Investigators. Muramatsu T, et al. Among authors: seth a. JACC Cardiovasc Interv. 2014 May;7(5):482-93. doi: 10.1016/j.jcin.2014.01.155. Epub 2014 Apr 16. JACC Cardiovasc Interv. 2014. PMID: 24746650 Free article.
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.
Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW; ABSORB EXTEND investigators. Abizaid A, et al. Among authors: seth a. EuroIntervention. 2015 Apr;10(12):1396-401. doi: 10.4244/EIJV10I12A243. EuroIntervention. 2015. PMID: 24769555 Free article.
1,538 results